Abrdn Life Sciences Investors (HQL)

Abrdn Life Sciences Investors (NYSE: HQL) is a U.S.-domiciled closed-end equity fund listed on the New York Stock Exchange. Managed by abrdn Inc., the fund focuses on public equity markets worldwide and seeks exposure to companies tied to the life sciences area. Its portfolio may include businesses involved in biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical devices, hospitals, healthcare information technology and related services, as well as devices and supplies. The mandate also extends to agriculture and environmental management companies. In practice, the fund emphasizes growth-oriented small-cap stocks and uses fundamental analysis that considers business positioning, management experience, technological expertise, and access to capital. Performance is measured against the NASDAQ Biotech Index and the S&P 500 Index. The fund was formed on February 20, 1992.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.